CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted EPS | ₹24.43 | ₹14.80 | ₹13.89 | ₹13.89 |
What is the latest Earnings Per Share (EPS) of CORONA REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹24.43 |
| Mar2025 | ₹14.80 |
| Mar2024 | ₹13.89 |
| Mar2023 | ₹13.89 |
How is Earnings Per Share (EPS) of CORONA REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹24.43 | 65.07 | |
| Mar2025 | ₹14.80 | 6.55 | |
| Mar2024 | ₹13.89 | 0.00 | |
| Mar2023 | ₹13.89 | - | |
Compare Earnings Per Share (EPS) of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,133.8 Cr | 5.2% | 3.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 5.2% |
3.3% |
|
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses